Analysts Predict Shipments of Illumina's MiSeq will Top 600 in 2012 as HiSeq Orders Continue to Grow
June 07, 2011
Analysts Predict Shipments of Illumina's MiSeq will Top 600 in 2012 as HiSeq Orders Continue to Grow
The MiSeq will become an "important mechanism" for the company to continue to expand the next-generation sequencing market, with "meaningful penetration" into the CE space by 2013.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- NIPT and Cancer Drive Illumina's Clinical Business in Q1 as it Looks to Launch Fetal Aneuploidy IVD
April 24, 2013 / Clinical Sequencing News - Resurgence in HiSeq Sales Helps Drive Illumina Revenue Growth in Q1 2013
April 23, 2013 / In Sequence - MiSeq, Consumables, Services Drive Illumina's Q4 Revenues as it Begins Work on Nanopore Sequencing
January 29, 2013 / In Sequence - Analysts Increase Valuations, Upgrade Illumina
January 4, 2013 / GenomeWeb Daily News - BGI Reviews Next-Gen Sequencing Platforms, Highlighting Advantages of Each System
August 14, 2012 / In Sequence